Cholinesterase inhibitory and anti-amnesic activity of alkaloids from Corydalis turtschaninovii
Introduction
Alzheimer's disease (AD) is the most common age-related neurodegenerative disease with many cognitive and neuropsychiatric manifestations that result in progressive disability and eventual incapacitation. A decrease of acetylcholine in the brain of patients with AD appears to be a critical element in producing dementia (Becker et al., 1988). Loss of cholinergic cells, particularly in the basal forebrain, is accompanied by loss of the neurotransmitter acetylcholine. One approach is to inactivate acetylcholinesterase (AChE), the enzyme that cleaves synaptic acetylcholine and terminates neuronal signaling. AChE inhibitors increase the availability of acetylcholine in central cholinergic synapses and are the most promising currently available drugs for the treatment of AD (Giacobini, 2000). AChE inhibitors from general chemical classes such as physostigmine, tacrine, donepezil, galanthamine, huperzine A and heptylphysostigmine have been tested for the symptomatic treatment of AD. Although there have been a number of reports on the designing and development of synthetic AChE inhibitors, that were necessary for other studies, which have been reported the AChE inhibitors derived from medicinal plants (Oh et al., 2004, Houghton et al., 2006).
In our screening program to search for AChE inhibitors from plants, a 70% ethanolic extract of Corydalis turtschaninovii Besser forma yanhusuo (Papaveraceae) exhibited significant AChE inhibitory activity (72.5% at 100 μg/mL). Previously reports showed that several species of the genera Corydalis have been used in the treatment of memory dysfunction in folk medicine (Orhan et al., 2004, Houghton et al., 2006). Corydalis turtschaninovii have been used in traditional medicine for the treatment of gastric, duodenal ulcer, cardiac arrhythmia disease (Kamigauchi and Iwasa, 1994), rheumatism, dysmenorrheal (Tang and Eisenbrand, 1992), and memory dysfunction (Orhan et al., 2004, Houghton et al., 2006). This tuber contains several pharmacologically important alkaloids (Sagara et al., 1985, Matsuda et al., 1988, Saito et al., 2004). In this paper, we report the isolation and identification of two new quaternary, together with several alkaloids with regard to active principles in AChE activity, and anti-amnesic effect of pseudoberberine in mice.
Section snippets
Plant material
The tuber of Corydalis turtschaninovii were purchased at Yuseong oriental herbarium market in Daejeon, Korea on September 2006. The plant was botanically identified by Prof. KiHwan Bae, College of Pharmacy, Chungnam National University where the voucher specimens was deposited (CNU-00124).
Extraction and isolation
The tuber of Corydalis turtschaninovii (2.0 kg) were dried and extracted with 70% EtOH. The solution was evaporated and residue (110 g) was diluted with 3% aqueous HCl to give acidic solution and insoluble part.
Identification of active constituents
Repeated column chromatography led to the isolation of 16 compounds (1–16). All isolated compounds show positive with Dragendoff's reagent. The UV, IR, and other physico-chemical data showed that their chemical structures are belonging to isoquinoline alkaloid. Based on the mass, 1H, and 13C NMR spectra, the isolated alkaloids can be divided to two main skeletons: protoberberine and aporphine skeleton. By comparing spectral data with those reported in the literatures and authentic samples, the
Discussion
As mentioned earlier, AChE inhibitors increased the availability of acetylcholine in central cholinergic synapses and are the most promising currently available drugs for the treatment of AD (Giacobini, 1990, LeDoux, 1993). Scopolamine, which is a muscarinic receptor antagonist and can pass through blood–brain barrier causes amnesia in animals by blocking cholinergic neurotransmission. Cholinergic interneurons in the striatum are an even richer source of AChE and would also be affected strongly
Acknowledgments
This study was partially supported by a grant from the Korean Food and Drug Administration (2007). We are grateful to KBSI for measuring 1D, 2D NMR and MS spectra.
References (33)
- et al.
Acetylcholinesterase and butyrylcholinesterase inhibitory compounds from Corydalis cava Schweigg. & Kort.
Journal of Ethnopharmacology
(2007) - et al.
Serum proteins bypass the blood–brain fluid barriers for extracellular entry to the central nervous system
Experimental Neurology
(1993) The cholinergic system in Alzheimer disease
Progress in Brain Research
(1990)- et al.
Alkaloids from Corydalis
Phytochemistry
(1990) - et al.
Gomisin A improves scopolamine-induced memory impairment in mice
European Journal of Pharmacology
(2006) Emotional memory systems in the brain
Behavioural Brain Research
(1993)Development of a water maze procedure for studying spatial learning in the rat
Journal of Neuroscience Methods
(1984)- et al.
Screening of Korean herbal medicines used to improve cognitive function for anti-cholinesterase activity
Phytomedicine
(2004) - et al.
The protoberberine alkaloids of Stephania suberosa
Phytochemistry
(1987) - et al.
Effect of long-term administration of berberine on scopolamine-induced amnesia in rats
Japanese Journal of Pharmacology
(1997)
Corunnine and pontevedrine, two new aporphine alkaloids from Glaucium flavum Cr. var. Vestitum
Tetrahedron Letters
Effects of huperzine A on acetylcholinesterase isoforms in vitro: comparison with tacrine, donepezil, rivastigmine and physostigmine
European Journal of Pharmacology
Potential pharmacotherapy of Alzheimer disease. A comparison of various forms of physostigmine administration
Acta Neurologica Scandinavica
A new and rapid colorimetric determination of acetylcholinesterase activity
Biochemical Pharmacology
Acetylcholinesterase inhibitors from plants and fungi
Natural Products Reports
Cited by (78)
<sup>13</sup>C NMR spectroscopic data of aporphine alkaloids
2023, Alkaloids: Chemistry and BiologyCitation Excerpt :Natural source: Corydalis turtschaninovii124Unlabelled Image 13C NMR (75 MHz, CD3OD)124: 152.7 (C-1), 118.8 (C-1a), 124.5 (C-1b), 149.5 (C-2), 108.9 (C-3), 121.6 (C-3a), 156.7 (C-4), 113.9 (C-5), 130.8 (C-6a), 175.8 (C-7), 128.0 (C-7a), 112.6 (C-8), 154.1 (C-9), 150.1 (C-10), 108.9 (C-11), 124.1 (C-11a), 56.1 (1-OCH3), 60.7 (2-OCH3), 56.7 (9-OCH3), 56.1 (10-OCH3), 30.7 (N+–CH3). Natural source: Neolitsea parvigemma22Unlabelled Image
Alkaloids from Corydalis decumbens modulate neuronal excitability
2020, Bioorganic ChemistryCitation Excerpt :To date, several classes of isoquinoline alkaloids have been reported in this genus including aporphine, protopine, protoberberine, tetrahydroprotoberberine, benzo[c]phenanthridine, phthalideisoquinoline, benzylisoquinoline, morphinan, and spirobenzylisoquinoline [1]. These alkaloids exhibited various biological properties such as analgesic [3,4], anti-inflammatory [5,6], anti-cancer [7,8], acetylcholinesterase and butyrylcholinesterase inhibitory activities [9,10]. The bulb of C. decumbens, recorded as “Xiatianwu” in the Chinese Pharmacopoeia, is a commonly used traditional Chinese medicine for the treatment of post-stroke hemiplegia, headache, rheumatic arthritis, and traumatic injuries [11].
Establishment of a rapid and sensitive UPLC-MS/MS method for pharmacokinetic determination of nine alkaloids of crude and processed Corydalis turtschaninovii Besser aqueous extracts in rat plasma
2019, Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences